Pharmaceutical Research and Manufacturers of America

Pharmaceutical companies worry the Supreme Court’s abortion pill ruling could have a wider effect on drugs and research

by

A Supreme Court case over whether to tighten restrictions on mifepristone – one of two drugs used in the medication abortion regimen – could destabilize the American pharmaceutical industry, deterring companies from developing new drugs and even inspiring copycat lawsuits intended to revoke authorization of other politically contentious medications. Read more at 19th News  

US pharma group opposing abortion pill restrictions also backs Republicans attacking drug

by

A top trade group for pharmaceutical companies has asked the US supreme court not to shred the power of the Food and Drug Administration (FDA) in an upcoming case that could cut access to a drug commonly used in abortions. But in a move that appears to undermine its own position, it has also given … Read more